Abstract
Preclinical development of human cells for potential therapeutic application in neurodegenerative diseases requires that their long-term survival, stability and functional efficacy be studied in animal models of human disease. Here we describe a strategy for long-term immune protection of human fetal and stem cell-derived neural cells transplanted into the adult rat brain, by desensitizing the host rat to similar cells in the neonatal period, without the need for additional immunosuppression.
Original language | English |
---|---|
Pages (from-to) | 271-273 |
Number of pages | 3 |
Journal | Nature Methods |
Volume | 6 |
Issue number | 4 |
DOIs | |
Publication status | Published - 8 Mar 2009 |
Externally published | Yes |